These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1366200)

  • 1. [Spironolactone, potassium chloride and hyperkalemia in patients with kidney failure].
    Elo H
    Duodecim; 1992; 108(19):1708-10. PubMed ID: 1366200
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D; Frey FJ; Ferrari P
    Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone and ACE inhibition in chronic renal failure.
    Almirall J; Lopez T
    N Engl J Med; 2002 Feb; 346(6):456-7. PubMed ID: 11837270
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of aldosterone blockade in end-stage renal disease.
    Pitt B; Saran R
    Cardiology; 2009; 114(1):30-1. PubMed ID: 19342856
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients.
    Matsumoto Y; Kageyama S; Yakushigawa T; Arihara K; Sugiyama T; Mori Y; Sugiyama H; Ohmura H; Shio N
    Cardiology; 2009; 114(1):32-8. PubMed ID: 19342857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducing hyperkalemia by converting enzyme inhibitors and heparin.
    Durand D; Ader JL; Rey JP; Tran-Van T; Lloveras JJ; Bernadet P; Suc JM
    Kidney Int Suppl; 1988 Sep; 25():S196-7. PubMed ID: 3184611
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R
    Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening, preventable hyperkalemia in a nursing home resident: case report and literature review.
    Dharmarajan TS; Nguyen T; Russell RO
    J Am Med Dir Assoc; 2005; 6(6):400-5. PubMed ID: 16286062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined treatment with furosemide, aldactone and hygroton in chronic right-ventricular circulatory failure].
    Florkiewicz H; Rymar B; Rumiński W; Staśkiewicz J
    Wiad Lek; 1977 Aug; 30(15):1171-5. PubMed ID: 906465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperkalemias in cardiac patients].
    Raynaud R; Brochier M; Raynaud P; Fauchier JP
    Sem Hop; 1974 Oct; 50(40):2463-70. PubMed ID: 4374758
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prospective observational study of drug-induced hyperkalemia in hospitalized non dialized adult patients].
    Onno C; Rémignon H; Lagarce L; Bruhat C; Tourmen Y; Subra JF; Lainé-Cessac P
    Therapie; 2007; 62(1):55-60. PubMed ID: 17374349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone in patients with heart failure.
    Vanpee D; Swine C
    N Engl J Med; 2000 Jan; 342(2):133; author reply 133-4. PubMed ID: 10636753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M; Dzielski T; Wojciechowska J; Heller L; Trybus M
    Pol Merkur Lekarski; 1999 Aug; 7(38):69-70. PubMed ID: 10522422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life threatening hyperkalemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment.
    Margassery S; Bastani B
    J Nephrol; 2001; 14(5):410-4. PubMed ID: 11730276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemia associated with potassium chloride administration in a cat.
    Dhein CR; Wardrop KJ
    J Am Vet Med Assoc; 1995 May; 206(10):1565-6. PubMed ID: 7775234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
    Lenz T
    MMW Fortschr Med; 2005 Jan; 147(4):59-60. PubMed ID: 15745346
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart failure drug poses potassium problems. When using "the water pill" spironolactone, watch your potassium intake and check your levels.
    Harv Heart Lett; 2004 Dec; 15(4):3. PubMed ID: 15704264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.